Published in Stroke on October 28, 2014
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. N Engl J Med (2016) 3.74
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Obesity increases risk of ischemic stroke in young adults. Stroke (2015) 1.65
Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol (2012) 1.10
Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J (2016) 1.05
CHADS2 and CHA2DS2-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation. J Atheroscler Thromb (2016) 0.98
Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol (2015) 0.98
Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension. Stroke (2015) 0.94
Strokes in young adults: epidemiology and prevention. Vasc Health Risk Manag (2015) 0.90
Stroke Prevention Worldwide - What Could Make It Work? Neuroepidemiology (2015) 0.89
Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel NQO1*2 Polymorphism. J Investig Med High Impact Case Rep (2016) 0.87
mHealth For Aging China: Opportunities and Challenges. Aging Dis (2016) 0.86
Intracerebral Hemorrhage, Oxidative Stress, and Antioxidant Therapy. Oxid Med Cell Longev (2016) 0.84
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack. Am J Med (2015) 0.84
Impact of Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Degree of Severity: A Cross-Sectional Study. PLoS One (2015) 0.83
Design, methods and demographics from phase I of Alberta's Tomorrow Project cohort: a prospective cohort profile. CMAJ Open (2016) 0.83
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. Stroke (2017) 0.82
Risk of Stroke in Elderly Dialysis Patients. J Korean Med Sci (2017) 0.82
Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: The Taiwan Diabetes Study. Medicine (Baltimore) (2015) 0.82
The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease. Curr Cardiovasc Risk Rep (2015) 0.82
Aspirin for primary prevention of cardiovascular disease. Thromb J (2015) 0.82
The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis. Neurology (2016) 0.82
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies. PLoS One (2016) 0.81
[New oral anticoagulants for prophylaxis of stroke : Results of an expert conference on practical use in geriatric patients]. Z Gerontol Geriatr (2016) 0.80
Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart Survey. J Am Heart Assoc (2015) 0.80
A new prognostic scale for the early prediction of ischemic stroke recovery mainly based on traditional Chinese medicine symptoms and NIHSS score: a retrospective cohort study. BMC Complement Altern Med (2015) 0.80
Identifying Target Risk Factors Using Population Attributable Risks of Ischemic Stroke by Age and Sex. J Stroke (2015) 0.80
DASH (Dietary Approaches to Stop Hypertension) Diet and Risk of Subsequent Kidney Disease. Am J Kidney Dis (2016) 0.79
Stroke Risk Factors, Genetics, and Prevention. Circ Res (2017) 0.78
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. Biol Blood Marrow Transplant (2016) 0.78
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol (2016) 0.78
Risk Factors for Stroke among Young-Old and Old-Old Community-Dwelling Adults in Japan: The Ohasama Study. J Atheroscler Thromb (2016) 0.78
Aspirin resistance and other aspirin-related concerns. Neurol Sci (2015) 0.78
Cognitive impairment and stroke in elderly patients. Vasc Health Risk Manag (2016) 0.78
Personalized medicine and stroke prevention: where are we? Vasc Health Risk Manag (2015) 0.78
Mobile health as a viable strategy to enhance stroke risk factor control: A systematic review and meta-analysis. J Neurol Sci (2017) 0.78
Identification of Barriers to Stroke Awareness and Risk Factor Management Unique to Hispanics. Int J Environ Res Public Health (2015) 0.77
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Europace (2016) 0.77
CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study. J Am Heart Assoc (2015) 0.77
Use of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity? J Multidiscip Healthc (2015) 0.77
Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages. Semin Nephrol (2015) 0.77
Patients' views and experiences of technology based self-management tools for the treatment of hypertension in the community: A qualitative study. BMC Fam Pract (2015) 0.77
Field Synopsis of the Role of Sex in Stroke Prediction Models. J Am Heart Assoc (2016) 0.77
Migraine as a risk factor for young patients with ischemic stroke: a case-control study. Neurol Sci (2017) 0.76
Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease. Curr Alzheimer Res (2016) 0.76
Association between IL-10 gene polymorphisms and the risk of ischemic stroke in a Chinese population. Int J Clin Exp Pathol (2015) 0.76
Hypertension and Stroke in Patients with Left Ventricular Assist Devices (LVADs). Curr Hypertens Rep (2016) 0.76
First-ever ischemic stroke in elderly patients: predictors of functional outcome following carotid artery stenting. Clin Interv Aging (2016) 0.75
A Targeted Metabolomics MRM-MS Study on Identifying Potential Hypertension Biomarkers in Human Plasma and Evaluating Acupuncture Effects. Sci Rep (2016) 0.75
Cardioembolic Stroke. Circ Res (2017) 0.75
A Protocol-Based Decision for Choosing a Proper Surgical Treatment Option for Carotid Artery Stenosis. J Cerebrovasc Endovasc Neurosurg (2015) 0.75
Associations Between Blood Pressure and Outcomes Among Blacks in the Jackson Heart Study. J Am Heart Assoc (2016) 0.75
Mycophenolate Mofetil Prevents Cerebrovascular Injury in Stroke-prone Spontaneously Hypertensive Rats. Physiol Genomics (2016) 0.75
Is carotid sonography a useful tool for predicting functional capabilities in ischemic stroke patients following carotid artery stenting? Medicine (Baltimore) (2017) 0.75
The Association of Four-Limb Blood Pressure with History of Stroke in Chinese Adults: A Cross-Sectional Study. PLoS One (2015) 0.75
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair. Neurotherapeutics (2016) 0.75
Association of high waist-to-height ratio with functional outcomes in patients with acute ischemic stroke: A report from the ACROSS-China study. Medicine (Baltimore) (2017) 0.75
Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study. J Stroke Cerebrovasc Dis (2016) 0.75
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant (2016) 0.75
Where to Focus Efforts to Reduce the Black-White Disparity in Stroke Mortality: Incidence Versus Case Fatality? Stroke (2016) 0.75
Evaluating the Primary Prevention of Ischemic Stroke of Oral Antithrombotic Therapy in Head and Neck Cancer Patients with Radiation Therapy. Biomed Res Int (2016) 0.75
Primary Prevention of Stroke. JAMA (2016) 0.75
Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes). Stroke (2017) 0.75
Carotid Endarterectomy: Current Concepts and Practice Patterns. Int J Angiol (2015) 0.75
High blood pressure as a risk factor for incident stroke among very old people: a population-based cohort study. J Hypertens (2016) 0.75
The Cost Effectiveness of LAA Exclusion. J Atr Fibrillation (2016) 0.75
Internal Carotid Artery Stenosis Presenting with Limb Shaking TIA. Case Rep Neurol Med (2016) 0.75
Behavioral Interventions for Stroke Prevention: The Need for a New Conceptual Model. Stroke (2017) 0.75
Quantitative Assessment of Left Ventricular Function and Myocardial Mass: A Comparison of Coronary CT Angiography with Cardiac MRI and Echocardiography. Pol J Radiol (2016) 0.75
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery Stenting. Cerebrovasc Dis Extra (2017) 0.75
Knowledge of Stroke Risk Factors among Stroke Survivors in Nigeria. Stroke Res Treat (2016) 0.75
Within-the-Clinic Shared Decision for an Over-the-Counter Medication. J Am Heart Assoc (2015) 0.75
Clinician time used for decision making: a best case workflow study using cardiovascular risk assessments and Ask Mayo Expert algorithmic care process models. BMC Med Inform Decis Mak (2016) 0.75
Minimal invasive puncture and drainage versus endoscopic surgery for spontaneous intracerebral hemorrhage in basal ganglia. Neuropsychiatr Dis Treat (2017) 0.75
The Devil Is in the Details: Achieving Reductions in Global Cardiovascular Disease Mortality. Circ Cardiovasc Qual Outcomes (2015) 0.75
Cardiovascular Pharmacogenomics-Implications for Patients With CKD. Adv Chronic Kidney Dis (2016) 0.75
Association between television viewing time and risk of incident stroke in a general population: Results from the REGARDS study. Prev Med (2016) 0.75
Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population. PLoS One (2016) 0.75
Risk of Diabetes Mellitus on Incidence of Out-of-Hospital Cardiac Arrests: A Case-Control Study. PLoS One (2016) 0.75
Stroke rehabilitation. A call to action in Saudi Arabia. Neurosciences (Riyadh) (2016) 0.75
Nontyphoidal Salmonellosis, Human Immunodeficiency Virus Infection, and Ischemic Stroke. Open Forum Infect Dis (2016) 0.75
Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. J Am Heart Assoc (2016) 0.75
Transcatheter Closure of Patent Foramen Ovale: A Single Center Experience. Open Access Maced J Med Sci (2016) 0.75
Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options. Int J Gen Med (2015) 0.75
Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis. Neuroradiology (2016) 0.75
A Diagnostic Approach to Stroke in Young Adults. Curr Treat Options Cardiovasc Med (2017) 0.75
The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review. Intern Emerg Med (2017) 0.75
Juvenile Stroke. Dtsch Arztebl Int (2017) 0.75
Smoking cessation and outcome after ischemic stroke or TIA. Neurology (2017) 0.75
Sleep apnoea and stroke. Stroke Vasc Neurol (2016) 0.75
Physical Activity Frequency and the Risk of Stroke: A Nationwide Cohort Study in Korea. J Am Heart Assoc (2017) 0.75
Factors Influencing Decision Making for Carotid Endarterectomy versus Stenting in the Very Elderly. Front Neurol (2017) 0.75
Relationship between pre-stroke cardiovascular medication use and stroke severity. Eur J Clin Pharmacol (2015) 0.75
Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. Ann Rheum Dis (2017) 0.75
Risk Factors and Etiology of Young Ischemic Stroke Patients in Estonia. Stroke Res Treat (2017) 0.75
Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives? Endosc Int Open (2017) 0.75
Genetic Variant of Kalirin Gene Is Associated with Ischemic Stroke in a Chinese Han Population. Biomed Res Int (2017) 0.75
Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset. Eur Arch Psychiatry Clin Neurosci (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA (2012) 28.69
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA (1995) 26.76
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med (2006) 24.62
Genomewide association analysis of coronary artery disease. N Engl J Med (2007) 24.38
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98
A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 20.37
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
The metabolic syndrome. Lancet (2005) 19.47
U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr (2011) 19.32
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA (2013) 18.86
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet (2005) 17.31
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (2012) 17.29
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med (2011) 15.30
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27
Cardiac myxomas. N Engl J Med (1995) 14.96
The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84
Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med (2002) 14.26
Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med (2008) 14.01
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep (2008) 13.54
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med (1999) 12.71
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet (2003) 12.67
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA (1995) 11.45
SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med (2008) 11.31
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med (2013) 11.14
Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief (2012) 10.88
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Obesity and metabolic syndrome in circadian Clock mutant mice. Science (2005) 12.66
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81
Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension (2006) 8.72
Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep (2005) 8.15
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One (2008) 7.16
Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation (2005) 7.04
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med (2010) 6.21
The science of stroke: mechanisms in search of treatments. Neuron (2010) 6.14
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
The metabolic syndrome. Endocr Rev (2008) 5.33
Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation (2006) 5.31
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol (2007) 4.68
Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 4.59
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol (1985) (2006) 4.43
Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA (2003) 4.38
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14
Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke (2003) 4.13
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res (2002) 4.09
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
The neural basis of functional brain imaging signals. Trends Neurosci (2002) 4.01
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93